Journey Medical Corporation (DERM)
NCM – Real vaqt narxi. Valyuta: USD
4.58
-0.20 (-4.29%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
4.77
+0.20 (4.36%)
Bozordan keyin: Mar 27, 2026, 7:15 PM EDT

NCM – Real vaqt narxi. Valyuta: USD
4.58
-0.20 (-4.29%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
4.77
+0.20 (4.36%)
Bozordan keyin: Mar 27, 2026, 7:15 PM EDT
Journey Medical Corporation Qo'shma Shtatlarda dermatologik kasalliklarni davolash uchun farmatsevtika mahsulotlarini ishlab chiqish va tijoratlashtirishga e'tibor qaratadi. Kompaniyaning sotilayotgan mahsulotlari orasida birinchi darajali aksillyar gipergidrozni davolash uchun dori-darmonli salfetka bo'lgan Qbrexza; og'ir refrakter nodulyar akne davolash uchun og'zaki izotretinoin preparati Accutane; va nodulyar bo'lmagan o'rtacha yoki og'ir akne vulgarisning yallig'lanishli lezyonlarini davolash uchun minotsiklindan tayyorlangan topikal preparat Amzeeq mavjud. U, shuningdek, rozatseyaning yallig'lanishli lezyonlarini davolash uchun topikal minotsiklinli davolash Zilxi; qo'ziqorinli teri infektsiyalarini davolash uchun Exelderm; va og'ir akne uchun qo'shimcha terapiya uchun og'zaki doksitsiklin preparati Targadox; rozatseyaning yallig'lanishli lezyonlarini davolash uchun Emrosi, shuningdek, yuzaki yaralar; mayda kesilgan joylar yoki tirnalishlar; dermal yaralar; donor joylari; quyosh yonishi, shu jumladan birinchi va ikkinchi darajali kuyishlar; va radiatsion dermatit uchun nam shifo muhitini ta'minlash uchun ishlab chiqilgan suv asosidagi emulsiyali Luxamendni taklif etadi. Kompaniya ilgari Coronado Dermatology, Inc. nomi bilan tanilgan. Journey Medical Corporation 2014 yilda tashkil etilgan va shtab-kvartirasi Skotsdeyl, Arizona shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Lindsay Allan Rosenwald M.D. | Executive Chairman |
| Jaclyn Jaffe | Senior Director of Corporate Operations |
| Mr. Claude Maraoui | Founder, President, CEO & Director |
| Mr. Joseph M. Benesch | CFO & Corporate Controller |
| Mr. Louis Donati | Director of Market Access |
| Mr. Ramsey Alloush | COO, General Counsel & Company Secretary |
| Mr. Robert Nevin | Chief Commercial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-01-15 | S-3 | tm2534369d2_s3.htm |
| 2025-12-30 | DRS | filename1.htm |
| 2025-11-12 | 10-Q | derm-20250930x10q.htm |
| 2025-09-26 | 8-K | tm2527082d1_8k.htm |
| 2025-08-28 | 8-K | tm2524202d2_8kseq1.htm |
| 2025-08-12 | 10-Q | derm-20250630x10q.htm |
| 2025-07-14 | 8-K | tm2520913d1_8k.htm |
| 2025-06-26 | 8-K | tm2519010d1_8k.htm |
| 2025-06-24 | 8-K | tm2518699d1_8k.htm |
| 2025-05-15 | 10-Q | derm-20250331x10q.htm |